PTC Therapeutics Inc (PTCT)

PTC Therapeutics Inc (PTCT) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $5.3B; returns 1 day -3.9%, 1 week +2.3%, 1 year -9.3%.

PTC Therapeutics Inc. is a global biopharmaceutical company dedicated to the discovery, development, and commercialization of clinically differentiated medicines for children and adults living with rare disorders, primarily focusing on neurological and metabolic conditions. The company generates revenue through product sales and royalty streams from partnered assets.

Groups PTCT belongs to

• Biotechnology
• Biopharmaceutical
• Rare Diseases
• Healthcare
• Commercial Stage
• Commercial Stage Biotech
• Duchenne Muscular Dystrophy
• Neurological Disorders
• Metabolic Disorders
• Neuroscience
• Pharmaceuticals
• Gene Therapy
• Royalty Streams

PTCT financial model: income statement, cash flow and balance sheet